New Protocols (12*)
* The protocols may appear repeatedly under different diseasesAcute Myeloid Leukemia
Anemia, Autoimmune Hemolytic Anemia
Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma
Immune Thrombocytopenia
Breast Cancer
Multiple Myeloma
NHL, T-Cell Type, Angioimmunoblastic
Thrombotic Thrombocytopenic Purpura
Tumor Biomarker Defined
Soft Tissue Sarcoma
Updated Protocols (0*)
* The protocols may appear repeatedly under different diseasesProtocols in Revision
Head and Neck Tumors (Squamous Cell)
- Carboplatin 70 / Fluorouracil 600 / Radiation, Oropharyngeal Carcinoma PID 1708 V1.1
Breast Cancer
- STUDY - GAIN-2 - Pertuzumab 420 / Trastuzumab 6, Breast Cancer, neoadjuvant, cycle 2-4 PID 768 V1.1
- STUDY - GAIN-2 - Pertuzumab 840 / Trastuzumab 8, Breast Cancer, neoadjuvant, cycle 1 PID 767 V1.1
Multiple Myeloma
- Bortezomib 1.3 / Lenalidomide 25 / Dexamethasone 20 / Isatuximab 10, multiple myeloma, induction, IB, cycle 1 PID 41 V1.2
- Bortezomib 1.3 / Lenalidomide 25 / Dexamethasone 20 / Isatuximab 10, multiple myeloma, induction, IB, cycle 2-3 PID 42 V1.2
Ovarian Tumor
- Paclitaxel 175 / Carboplatin 7.5, Ovarian ca, adjuvant PID 1335 V1.2
